ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SRTS vs TELA // EV/EBITDA & P/E VALUATION

Sensus Healthcare Inc. (NASDAQ) VS. TELA Bio Inc. (NASDAQ) • 15-METRIC TALLY: SRTS 6 — TELA 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRTS VS. TELA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SRTS TELA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 43.20% 67.70% -24.50 TELA /gross-margins <GO>
Return on Invested Capital (ROIC) -31.30% -35.00% +3.70 SRTS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield 0.73% — — TIE /fcf-yield <GO>
Operating Margin -37.50% -42.00% +4.50 SRTS /operating-margins <GO>
Net Profit Margin -28.10% -48.30% +20.20 SRTS /net-margins <GO>
Revenue Growth (YoY) -34.30% 15.80% -50.10 TELA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.50 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 SRTS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.3 33.8 +5.50 SRTS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $45.6M $41.5M $4.1M SRTS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SRTS REV TELA REV SRTS GROSS % TELA GROSS % SRTS FCF TELA FCF
FY 2025 $27.5M $80.3M 43.2% 67.7% $332.0K -$28.7M
FY 2024 $41.8M $69.3M 58.4% 67.1% -$1.1M -$42.6M
FY 2023 $24.4M $58.5M — — -$2.1M -$40.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRTS // BETA —
TELA // BETA —